ASHPOfficial

COVID 19 Well-Being and Resilience: Managing Workforce Fatigue and Organizational Best Practices During the COVID Pandemic

Our ASHP members are in various stages of preparing for, responding to, and recovering from the COVID-19 global pandemic. This is an extremely difficult time and as we – pharmacists, pharmacy residents, students pharmacists, and pharmacy technicians - continue to care for our patients, it is even more imperative to step-up our well-being for ourselves and the healthcare workforce community. Today, we chat with Jennifer Phillips and Jennifer Locker about managing resilience and well-being of staff members during the COVID pandemic.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From the Frontline of COVID-19: Clinician Perspectives on Geriatric Practice Considerations

ASHP sits down with Drs. Amie Blaszczyk, PharmD, BCGP, BCPS, FASCP, Associate Professor and Division Head-Geriatrics at Texas Tech University Health Sciences Center in Dallas, Texas and Dana Carroll PharmD., BCGP, BCPS, CDE, Clinical Professor at the Auburn University Harrison School of Pharmacy in Auburn, Alabama as they discuss geriatric practice considerations in the long term care and ambulatory care settings at this time. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Distance Learning: COVID-19 Experiential Rotations and the Virtual Classroom

Today on ASHPOfficial, we chat with Dr. Amanda Margolis, PharmD, MS, BCACP and Dr. Marina Maes, PharmD, BCPS, BCACP, assistant professors at the University of Wisconsin-Madison School of Pharmacy in the pharmacy practice division. Dr. Margolis and Dr. Maes dive into how they are adapting to this evolving situation and share key insights into what teaching and practice model looks during COVID-19.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Therapeutic Thursdays: A conversation about the 2019 Community Acquired Pneumonia Guidelines

Join ASHP for a  discussion concerning the updates from the 2019 IDSA/ATS Community Acquired Pneumonia Guidelines published in October of 2019. These guidelines are an update to the previous 2007 guidelines with new information on outpatient and inpatient management, as well as topics the previous guidelines did not address, such as aspiration pneumonia and the use of corticosteroids.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Expansion of Telehealth Pharmacy Services in the Face of the COVID-19 Pandemic

Due to the COVID-19 pandemic, ambulatory care clinics have transitioned to telehealth services to allow for continued care of patients, while minimizing possible exposure to COVID-19.  This podcast will explore the implementation and expansion of telehealth pharmacy services in two different ambulatory care clinics in response to the COVID-19 pandemic.  Speakers will discuss the types of telehealth visits provided, the roadblocks encountered, lessons learned, and reimbursement.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

 

Keeping Up to Date: Revisiting ASHP’s Assessment of Evidence for COVID-19 Related Treatments

Eric Maroyka sits down with Elaine Snow to discuss how her team amends the evidence table and works with ASHP to ensure that pharmacists are working with the most up to date information concerning patient care. Listen in as they explore  ASHP’s Assessment of Evidence for COVID-19 Related Treatments and how pharmacists can apply this information to their practice. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

COVID-19: Clinician Perspectives on the Society of Critical Care Medicine’s Guidelines on Managing Critically Ill Patients

ASHP sits down with Dr. Amy L. Dzierba, Pharm.D. FCCM, FCCP, BCCCP, Clinical Pharmacy Manager of Adult Critical Care at New York-Presbyterian Hospital Columbia University Irving Medical Center to discuss the Society of Critical Care Medicine’s Guidelines on managing critically ill COVID-19 patients and how pharmacists can apply what is in these guidelines to their practice. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

COVID-19 Pharmacy Response in New York City Region: Lessons Learned From NYC Region Pharmacy Leadership

This episode is a recording of the ASHP COVID-19 Series (No CE) (Webinar)

Activity Date: April 17, 2020

This activity describes the journey of Mount Sinai Health System and Montefiore Health System, as well as the coordinated efforts of the New York City’s Pharmacy Leadership. Mr. Sosnowski and Mr. Pinto will share experiences and responses to this surge that will help hospitals and health systems prepare for the rapid changes and challenges facing hospitals during this pandemic.

Objectives:

• Managing Patient Surge
• Managing Drugs and Supplies
• Coordinating Staff and Working with Interprofessional Teams
• Patient and Family Experience
• Community Engagement and Hospital’s Role
• Surge Management: Facilities and Patient Transfers
• COVID-19 Exposure – Healthcare Leader’s Perspective

Speakers:

• Joseph Pinto, R.Ph, M.S., MHA, DPLA, Executive Director of Pharmacy Operations, Mount Sinai Health System, New York, NY
• Frank P. Sosnowski, B.S.Pharm., M.S., Senior Director of Pharmacy, Montefiore Medical Center, Bronx, NY
• Moderator: David Chen, B.S.Pharm., M.B.A., Assistant Vice President for Pharmacy Leadership and Planning, Office of Member Relations, ASHP, Bethesda, MD

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

Advocating for Impact: Demystifying Lobbying and Advocacy on behalf of Pharmacists

Join Dr. Melinda (Mindy) T. Burnworth, Pharm.D., BCPS, FASHP, from Midwestern University College of Pharmacy-Glendale and Dr. Janet Lee, Pharm.D, MPA, MBA, of the Department of Pharmacy – The Johns Hopkins Hospital, Baltimore, Md. and as they chat members of ASHP’s Office of Government Relations team to demystify the Hill, lobbying and advocacy on behalf of pharmacists.

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

COVID-19: A tale of two ICUS

Two of New York Presbyterian's Critical Care Pharmacists, Karen Berger and Amy Dzerba sit down with ASHP's Vicki Basalyga and discuss their experiences caring for critically ill patients in thier intensive care units and their strategies for sedation, anticoagulation and how they share successful strategies across a health system. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.